Citations

Showing 10 of 108162 citations.

The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence
Chandrasekar, Aswath P. , Cummins, Nathan W. , Badley, Andrew D. , Cummins, Nathan W , Badley, Andrew D

Mayo Clinic

Clinical Microbiology Reviews | October 29, 2019 | Volume: 33 | Issue: 1 | Pages: No page available

10.1128/cmr.00107-19 | PMID 31666279 Get It

Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape.
State of the Art in Abdominal CT: The Limits of Iterative Reconstruction Algorithms
Mileto, Achille , Guimarães, Luís , McCollough, Cynthia H. , Fletcher, Joel G. , Yu, Lifeng , Guimaraes, Luis S , Fletcher, Joel G , McCollough, Cynthia H , Yu, Lifeng

Mayo Clinic

Radiology | October 29, 2019 | Volume: 293 | Issue: 3 | Pages: 491-503

10.1148/radiol.2019191422 | PMID 31660806 Get It

A pilot exploratory study comparing the King-Devick test (KDT) during and between migraine attacks
Chiang, Chia‐Chun , Starling, Amaal J. , Buras, Matthew , Golafshar, Michael A. , VanderPluym, Juliana H. , Chiang, Chia-Chun , Buras, Matthew R , Golafshar, Michael , VanderPluym, Juliana

Mayo Clinic

Cephalalgia | October 29, 2019 | Volume: 40 | Issue: 3 | Pages: 307-312

10.1177/0333102419885381 | PMID 31660762 Get It

Background The King-Devick test is a timed rapid number naming task that involves complex cerebral functions. The objective of this pilot exploratory study is to determine whether there is a difference in the King-Devick test during a migraine attack compared to the interictal phase. Methods We evaluated 29 adult subjects with migraine with aura or migraine without aura. For each participant, we performed King-Devick tests during migraine attacks and interictal phases. Subjects served as their own controls. Results The King-Devick test was slower during the migraine attack compared to the interictal baseline (median 4.6 sec slower, p < 0.001). The slowing of the King-Devick test during migraine attack was more prominent in those with migraine with aura compared to subjects with migraine without aura (median 7.5 vs. 2.8 sec, p = 0.028). Conclusions This exploratory, observational study shows changes in the King-Devick test during migraine compared to the interictal phase. Future studies are required to determine if the King-Devick test may be used as a rapid and simple tool to objectively characterize migraine-associated disability.
Early prediction of transition to durable mechanical circulatory support in patients undergoing peripheral veno‐arterial extracorporeal membrane oxygenation for critical cardiogenic shock
Prasad, Amit , Goldenberg, Michael , Ghodsizad, Ali , Koerner, Michael M., El‐Banayosy, Aly, Singbartl, Kai , Singbartl, Kai , Brehm, Christoph E., Koerner, Michael Matthias

Mayo Clinic

Artificial Organs | October 29, 2019 | Volume: 44 | Issue: 4 | Pages: 402-410

10.1111/aor.13590 | PMID 31660618 Get It

Abstract Peripheral veno‐arterial extracorporeal membrane oxygenation (pVA‐ECMO) has gained increasing value in the management of patients with critical cardiogenic shock (cCS), allowing time for myocardial recovery. Failure of myocardial recovery has life‐altering consequences: transition to durable mechanical circulatory support (dMCS), urgent heart transplantation, or withdrawal of support. Clinical factors controlling myocardial recovery under these circumstances remain largely unknown. Using a retrospective cohort, we developed a model for early prediction of transition to dMCS in patients undergoing pVA‐ECMO for cCS. To promote myocardial recovery, our clinical management centered around left ventricular pressure unloading, that is, targeting pulmonary capillary wedge pressures (PCWP) ≤18 mm Hg. We collected demographic data, laboratory findings, inotrope use, and two‐dimensional transthoracic echocardiography measurements, all limited to the first 72h of pVA‐ECMO (D1‐3). Out of 70 patients who were alive after pVA‐ECMO, 27 patients underwent implantation of dMCS. There was no significant difference in survival to hospital discharge between patients with or without transition to dMCS. Ejection fraction D1‐3 (per 10% increase, OR 0.37 [0.17‐0.79]) and amount of inotropic support D1‐3 (OR 4.77 [1.6‐14.18]) but neither myocardial wall tension nor PCWP emerged as significant predictors of transition to dMCS. Optimism‐corrected c‐index (0.90 [0.89‐0.90]) revealed an excellent discriminative ability of our model. In summary, our model for early prediction of transition to dMCS in patients with cCS undergoing pVA‐ECMO identifies indicators of inotropic state as relevant factors. Absence of markers for myocardial oxygen consumption or left ventricular pressure loading allows us to hypothesize sufficient cardiac unloading in our cohort with PCWP‐targeted management.
Mechanisms of Human Immunodeficiency Virus-Associated Lymphocyte Regulated Cell Death
Paim, Ana C. , Badley, Andrew D. , Badley, Andrew D , Cummins, Nathan W.

Mayo Clinic

AIDS Research and Human Retroviruses | October 29, 2019 | Volume: 36 | Issue: 2 | Pages: 101-115

10.1089/aid.2019.0213 | PMID 31659912 Get It

Stereotactic radiosurgery for cavernous malformations
Flemming, Kelly D. , Flemming, Kelly D , Lanzino, Giuseppe

Mayo Clinic

Neurology | October 29, 2019 | Volume: 93 | Issue: 21 | Pages: 921-922

10.1212/wnl.0000000000008516 | PMID 31659094 Get It

Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Retrosigmoid Approach
Graffeo, Christopher S. , Peris‐Celda, Maria , Perry, Avital , Driscoll, Colin L. W., Link, Michael J. , Carlstrom, Lucas P.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | October 28, 2019 | Volume: 82 | Issue: 03 | Pages: 321-332

10.1055/s-0039-1700513 | PMID 34026408 Get It

Abstract Introduction Neurosurgical anatomy is traditionally taught via anatomic and operative atlases; however, these resources present the skull base using views that emphasize three-dimensional (3D) relationships rather than operative perspectives, and are frequently written above a typical resident's understanding. Our objective is to describe, step-by-step, a retrosigmoid approach dissection, in a way that is educationally valuable for trainees at numerous levels. Methods Six sides of three formalin-fixed latex-injected specimens were dissected under microscopic magnification. A retrosigmoid was performed by each of three neurosurgery residents, under supervision by the senior authors (C.L.W.D. and M.J.L.) and a graduated skull base fellow, neurosurgeon, and neuroanatomist (M.P.C.). Dissections were supplemented with representative case applications. Results The retrosigmoid craniotomy (aka lateral suboccipital approach) affords excellent access to cranial nerve (CN) IV to XII, with corresponding applicability to numerous posterior fossa operations. Key steps include positioning and skin incision, scalp and muscle flaps, burr hole and parasigmoid trough, craniotomy flap elevation, initial durotomy and deep cistern access, completion durotomy, and final exposure. Conclusion The retrosigmoid craniotomy is a workhorse skull base exposure, particularly for lesions located predominantly in the cerebellopontine angle. Operatively oriented neuroanatomy dissections provide trainees with a critical foundation for learning this fundamental skull base technique. We outline a comprehensive approach for neurosurgery residents to develop their familiarity with the retrosigmoid craniotomy in the cadaver laboratory in a way that simultaneously informs rapid learning in the operating room, and an understanding of its potential for wide clinical application to skull base diseases.
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307
Gralow, Julie R. , Barlow, William E. , Paterson, Alexander , Lew, Danika L., Stopeck, Alison , Hayes, Daniel F. , Hershman, Dawn L. , Schubert, Mark M., Clemons, Mark , Poznak, Catherine Van , Dees, Elizabeth Claire , Messino, Michael J., Margolis, Jeffrey, Dakhil, Shaker R. , Chew, Helen K. , Dammann, Kim Z, Abrams, Jeffrey S. , Livingston, Robert B., Ingle, James N. , Hershman, Dawn L , Gralow, Julie R , Barlow, William E , Miao, Jieling , Falkson, Carla I. , Elias, Anthony , Hortobágyi, Gabriel N.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | October 28, 2019 | Volume: 112 | Issue: 7 | Pages: 698-707

10.1093/jnci/djz215 | PMID 31693129 Get It

Abstract Background Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadian Cancer Trials Group/ECOG-ACRIN/NRG Oncology study S0307 compared the efficacy of three bisphosphonates in early-stage breast cancer. Methods Patients with stage I–III breast cancer were randomly assigned to 3 years of intravenous zoledronic acid, oral clodronate, or oral ibandronate. The primary endpoint was disease-free survival (DFS) with overall survival as a secondary outcome. All statistical tests were two-sided. Results A total of 6097 patients enrolled. Median age was 52.7 years. Prior to being randomly assigned, 73.2% patients indicated preference for oral vs intravenous formulation. DFS did not differ across arms in a log-rank test (P = .49); 5-year DFS was 88.3% (zoledronic acid: 95% confidence interval [CI] = 86.9% to 89.6%), 87.6% (clodronate: 95% CI = 86.1% to 88.9%), and 87.4% (ibandronate: 95% CI = 85.6% to 88.9%). Additionally, 5-year overall survival did not differ between arms (log rank P = .50) and was 92.6% (zoledronic acid: 95% CI = 91.4% to 93.6%), 92.4% (clodronate: 95% CI = 91.2% to 93.5%), and 92.9% (ibandronate: 95% CI = 91.5% to 94.1%). Bone as first site of recurrence did not differ between arms (P = .93). Analyses based on age and tumor subtypes showed no treatment differences. Grade 3/4 toxicity was 8.8% (zoledronic acid), 8.3% (clodronate), and 10.5% (ibandronate). Osteonecrosis of the jaw was highest for zoledronic acid (1.26%) compared with clodronate (0.36%) and ibandronate (0.77%). Conclusions We found no evidence of differences in efficacy by type of bisphosphonate, either in overall analysis or subgroups. Despite an increased rate of osteonecrosis of the jaw with zoledronic acid, overall toxicity grade differed little across arms. Given that patients expressed preference for oral formulation, efforts to make oral agents available in the United States should be considered.
Reveal, Don’t Conceal
Weissgerber, Tracey L. , Heinzen, Ethan P. , Milin‐Lazović, Jelena , Valencia, Oscar A. Garcia , Bukumirić, Zoran , Savić, Marko , Milić, Nataša , Garcia-Valencia, Oscar , Weissgerber, Tracey L , Milic, N , Bukumiric, Zoran , Winham, Stacey J. , Garovic, Vesna D.

Mayo Clinic

Circulation | October 28, 2019 | Volume: 140 | Issue: 18 | Pages: 1506-1518

10.1161/circulationaha.118.037777 | PMID 31657957 Get It

Reports highlighting the problems with the standard practice of using bar graphs to show continuous data have prompted many journals to adopt new visualization policies. These policies encourage authors to avoid bar graphs and use graphics that show the data distribution; however, they provide little guidance on how to effectively display data. We conducted a systematic review of studies published in top peripheral vascular disease journals to determine what types of figures are used, and to assess the prevalence of suboptimal data visualization practices. Among papers with data figures, 47.7% of papers used bar graphs to present continuous data. This primer provides a detailed overview of strategies for addressing this issue by (1) outlining strategies for selecting the correct type of figure depending on the study design, sample size, and the type of variable; (2) examining techniques for making effective dot plots, box plots, and violin plots; and (3) illustrating how to avoid sending mixed messages by aligning the figure structure with the study design and statistical analysis. We also present solutions to other common problems identified in the systematic review. Resources include a list of free tools and templates that authors can use to create more informative figures and an online simulator that illustrates why summary statistics are meaningful only when there are enough data to summarize. Last, we consider steps that investigators can take to improve figures in the scientific literature.
Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients
Kunchok, Amy , Chen, John J. , Mills, John R. , Pittock, Sean J. , Pittock, S J , Pittock, Sean J , Chen, John J , McKeon, Andrew , Flanagan, Eoin P.

Mayo Clinic

JAMA Neurology | October 28, 2019 | Volume: 77 | Issue: 2 | Pages: 257

10.1001/jamaneurol.2019.3656 | PMID 31657826 Get It